BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 19566834)

  • 1. Allosteric networks governing regulation and catalysis of Src-family protein tyrosine kinases: implications for disease-associated kinases.
    Cheng HC; Johnson TM; Mills RD; Chong YP; Chan KC; Culvenor JG
    Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):93-101. PubMed ID: 19566834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural elements and allosteric mechanisms governing regulation and catalysis of CSK-family kinases and their inhibition of Src-family kinases.
    Ia KK; Mills RD; Hossain MI; Chan KC; Jarasrassamee B; Jorissen RN; Cheng HC
    Growth Factors; 2010 Oct; 28(5):329-50. PubMed ID: 20476842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous and synthetic inhibitors of the Src-family protein tyrosine kinases.
    Chong YP; Ia KK; Mulhern TD; Cheng HC
    Biochim Biophys Acta; 2005 Dec; 1754(1-2):210-20. PubMed ID: 16198159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)--endogenous negative regulators of Src-family protein kinases.
    Chong YP; Mulhern TD; Cheng HC
    Growth Factors; 2005 Sep; 23(3):233-44. PubMed ID: 16243715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The regulation of N-methyl-D-aspartate receptors by Src kinase.
    Groveman BR; Feng S; Fang XQ; Pflueger M; Lin SX; Bienkiewicz EA; Yu X
    FEBS J; 2012 Jan; 279(1):20-8. PubMed ID: 22060915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Csk-homologous kinase (Chk) is an efficient inhibitor of Src-family kinases but a poor catalyst of phosphorylation of their C-terminal regulatory tyrosine.
    Advani G; Lim YC; Catimel B; Lio DSS; Ng NLY; Chüeh AC; Tran M; Anasir MI; Verkade H; Zhu HJ; Turk BE; Smithgall TE; Ang CS; Griffin M; Cheng HC
    Cell Commun Signal; 2017 Aug; 15(1):29. PubMed ID: 28784162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors.
    Roskoski R
    Pharmacol Res; 2015 Apr; 94():9-25. PubMed ID: 25662515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis for regulation of Src by the docking protein p130Cas.
    Nasertorabi F; Tars K; Becherer K; Kodandapani R; Liljas L; Vuori K; Ely KR
    J Mol Recognit; 2006; 19(1):30-8. PubMed ID: 16245368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Src family tyrosine kinases participate in insulin-like growth factor I mitogenic signaling in 3T3-L1 cells.
    Boney CM; Sekimoto H; Gruppuso PA; Frackelton AR
    Cell Growth Differ; 2001 Jul; 12(7):379-86. PubMed ID: 11457735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-terminal Src kinase-homologous kinase (CHK), a unique inhibitor inactivating multiple active conformations of Src family tyrosine kinases.
    Chong YP; Chan AS; Chan KC; Williamson NA; Lerner EC; Smithgall TE; Bjorge JD; Fujita DJ; Purcell AW; Scholz G; Mulhern TD; Cheng HC
    J Biol Chem; 2006 Nov; 281(44):32988-99. PubMed ID: 16959780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement.
    Moarefi I; LaFevre-Bernt M; Sicheri F; Huse M; Lee CH; Kuriyan J; Miller WT
    Nature; 1997 Feb; 385(6617):650-3. PubMed ID: 9024665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells.
    Hochgräfe F; Zhang L; O'Toole SA; Browne BC; Pinese M; Porta Cubas A; Lehrbach GM; Croucher DR; Rickwood D; Boulghourjian A; Shearer R; Nair R; Swarbrick A; Faratian D; Mullen P; Harrison DJ; Biankin AV; Sutherland RL; Raftery MJ; Daly RJ
    Cancer Res; 2010 Nov; 70(22):9391-401. PubMed ID: 20861192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Src-family kinases in formation of the cortical actin cap at the dorsal cell surface.
    Kuga T; Hoshino M; Nakayama Y; Kasahara K; Ikeda K; Obata Y; Takahashi A; Higashiyama Y; Fukumoto Y; Yamaguchi N
    Exp Cell Res; 2008 Jun; 314(10):2040-54. PubMed ID: 18457834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine phosphorylation of protein kinase CK2 by Src-related tyrosine kinases correlates with increased catalytic activity.
    Donella-Deana A; Cesaro L; Sarno S; Ruzzene M; Brunati AM; Marin O; Vilk G; Doherty-Kirby A; Lajoie G; Litchfield DW; Pinna LA
    Biochem J; 2003 Jun; 372(Pt 3):841-9. PubMed ID: 12628006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine phosphatases such as SHP-2 act in a balance with Src-family kinases in stabilization of postsynaptic clusters of acetylcholine receptors.
    Camilleri AA; Willmann R; Sadasivam G; Lin S; Rüegg MA; Gesemann M; Fuhrer C
    BMC Neurosci; 2007 Jul; 8():46. PubMed ID: 17605785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ABL1, SRC and other non-receptor protein tyrosine kinases as new targets for specific anticancer therapy].
    Klener P; Klener P
    Klin Onkol; 2010; 23(4):203-9. PubMed ID: 20806817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of phagocyte migration and recruitment by Src-family kinases.
    Baruzzi A; Caveggion E; Berton G
    Cell Mol Life Sci; 2008 Jul; 65(14):2175-90. PubMed ID: 18385944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Src in solid tumors.
    Wheeler DL; Iida M; Dunn EF
    Oncologist; 2009 Jul; 14(7):667-78. PubMed ID: 19581523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of Src family kinases and therapeutic implications of their modulators.
    Kumar A; Jaggi AS; Singh N
    Fundam Clin Pharmacol; 2015 Apr; 29(2):115-30. PubMed ID: 25545125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are Src family kinases involved in cell cycle resumption in rat eggs?
    Talmor-Cohen A; Tomashov-Matar R; Eliyahu E; Shapiro R; Shalgi R
    Reproduction; 2004 Apr; 127(4):455-63. PubMed ID: 15047936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.